Rationale and design of the RT-AF study: Combination of rivaroxaban and ticagrelor in patients with atrial fibrillation and coronary artery disease undergoing percutaneous coronary intervention-Reference-Cited by-同舟云学术

Rationale and design of the RT-AF study: Combination of rivaroxaban and ticagrelor in patients with atrial fibrillation and coronary artery disease undergoing percutaneous coronary intervention

Published:2015-07 Issue: Volume:43 Page:129-132
ISSN:1551-7144
Container-title:Contemporary Clinical Trials
language:en
Short-container-title:Contemporary Clinical Trials

Author:

Gao Fei,Shen Hua,Wang Zhi Jian,Yang Shi Wei,Liu Xiao Li,Zhou Yu Jie

Publisher

Elsevier BV

Subject

Pharmacology (medical),General Medicine

Reference29 articles.

1. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC);Camm;Eur. Heart J.,2010

2. 2014 AHA/ACC/HRS Guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society;January;Circulation,2014

3. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting;Lip;Thromb. Haemost.,2010

4. European Society of Cardiology working group on thrombosis. 2014 ESC/EACTS Guidelines on myocardial revascularization;Windecker;Eur. Heart J.,2014

5. Meta-analysis of the combination of warfarin and dual antiplatelet therapy after coronary stenting in patients with indications for chronic oral anticoagulation;Gao;Int. J. Cardiol.,2011

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of anticoagulation in non-ST-elevation myocardial infarction: a contemporary narrative review;Expert Review of Cardiovascular Therapy;2024-05-14

2. Trends in Off-Label Indications of Non-Vitamin K Antagonist Oral Anticoagulants in Acute Coronary Syndrome;Reviews in Cardiovascular Medicine;2023-06-25

3. Non–Vitamin K Antagonist Oral Anticoagulants in Coronary Artery Disease;Hämostaseologie;2021-10-18

4. Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome and / or undergoing percutaneous coronary intervention;Kardiologia Polska;2020-06-25

5. Predicted effect of ticagrelor on the pharmacokinetics of dabigatran etexilate using physiologically based pharmacokinetic modeling;Scientific Reports;2020-06-16